NavDx logo with tagline Optimizing HPV+ Cancer Care
Download a Doctor Discussion Guide

Early warning HPV+ head & neck and anal cancer recurrence, delivered by a simple blood draw.

With cancer, there are often more questions than answers – but here’s what we know about the risk of HPV+ head & neck and anal cancer recurrence:  

Teal Information Icon

NavDx is the first and most clinically validated blood test that aids in the early detection of HPV-driven cancer

Teal icon with a clock pointing towards clock-wise, implying quickening time.

Detecting recurrence early, when disease burden is low, may improve your chances of long-term survivorship1,2

Red hourglass icon, implying time is ticking

Symptoms of cancer recurrence can be delayed or subtle

Red icon of an eye with a slash on it, implying limited visibility

Imaging and clinical exams can miss early signs of head & neck cancer and anal cancer recurrence3,4

Red icon of a calendar, with no dates filled in

Within 5 years of treatment, cancer comes back for up to 1 in 4 HPV+ head & neck cancer patients (recurrence)5,6

Red icon of a flag

Up to one half of first recurrences for head & neck cancer are in a new part of the body (distant metastasis)6

A man looks directly into the camera, confident. Text in teal and red read: "know your status" and, the letters highlighted in red "no status".

Ask. Test. Know.

Published studies of people who received treatment for HPV+ cancer show NavDx testing accurately and reliably predicted when cancer returned.7,8,4

For patients with HPV+ head & neck cancer

≥ 95%

of people with one positive test had cancer recur

≥ 98%

of people who routinely tested negative had no cancer recurrence

For patients with HPV+ anal cancer

≥ 96%

of people with one positive test had cancer recur

≥ 92.5%

of people who routinely tested negative had no cancer recurrence

Naveris is Here to Help

Want more details?

Do you have any questions about the NavDx test? We’re here to help. Fill out the form to contact us.

Submit